Our study will be the first to systematically measure CNS structural abnormalities in a large ME/CFS case-control study using gold-standard methods. It will Highlight CSF pressure, structural abnormalities, and neuroinflammation, with pathophysiological implementations in ME/CFS. Added to this will be collected biospecimens to perform extensive state-of-the art analyses with the ambition to identify diagnostic and prognostic biomarkers
The IRB review will kick off shortly.